![Alterations in acylcarnitines, amines, and lipids inform about the mechanism of action of citalopram/escitalopram in major depression | Translational Psychiatry Alterations in acylcarnitines, amines, and lipids inform about the mechanism of action of citalopram/escitalopram in major depression | Translational Psychiatry](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41398-020-01097-6/MediaObjects/41398_2020_1097_Fig1_HTML.png)
Alterations in acylcarnitines, amines, and lipids inform about the mechanism of action of citalopram/escitalopram in major depression | Translational Psychiatry
![PDF) Alterations in acylcarnitines, amines, and lipids inform about the mechanism of action of citalopram/escitalopram in major depression PDF) Alterations in acylcarnitines, amines, and lipids inform about the mechanism of action of citalopram/escitalopram in major depression](https://www.researchgate.net/publication/349739671/figure/fig1/AS:1003874932502528@1616353843291/Change-in-metabolite-levels-from-pre-treatment-to-8-weeks-post-treatment-with_Q320.jpg)
PDF) Alterations in acylcarnitines, amines, and lipids inform about the mechanism of action of citalopram/escitalopram in major depression
![PDF) Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients PDF) Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients](https://i1.rgstatic.net/publication/334240871_Metabolomic_signature_of_exposure_and_response_to_citalopramescitalopram_in_depressed_outpatients/links/5d1ece74458515c11c1296cc/largepreview.png)
PDF) Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients
![Frontiers | Effectiveness of Vortioxetine in Patients With Major Depressive Disorder in Real-World Clinical Practice: Results of the RELIEVE Study Frontiers | Effectiveness of Vortioxetine in Patients With Major Depressive Disorder in Real-World Clinical Practice: Results of the RELIEVE Study](https://www.frontiersin.org/files/Articles/824831/fpsyt-13-824831-HTML/image_m/fpsyt-13-824831-g001.jpg)
Frontiers | Effectiveness of Vortioxetine in Patients With Major Depressive Disorder in Real-World Clinical Practice: Results of the RELIEVE Study
![Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients | Translational Psychiatry Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients | Translational Psychiatry](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41398-019-0507-5/MediaObjects/41398_2019_507_Fig3_HTML.png)
Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients | Translational Psychiatry
![These highlights do not include all the information needed to use CITALOPRAM TABLETS safely and effectively. See full prescribing information for CITALOPRAM TABLETS. CITALOPRAM tablets, for oral use Initial U.S. Approval: 1998 These highlights do not include all the information needed to use CITALOPRAM TABLETS safely and effectively. See full prescribing information for CITALOPRAM TABLETS. CITALOPRAM tablets, for oral use Initial U.S. Approval: 1998](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=citalopram-tablets-usp-3.jpg&id=635719)
These highlights do not include all the information needed to use CITALOPRAM TABLETS safely and effectively. See full prescribing information for CITALOPRAM TABLETS. CITALOPRAM tablets, for oral use Initial U.S. Approval: 1998
![Antidepressants affect gut microbiota and Ruminococcus flavefaciens is able to abolish their effects on depressive-like behavior | Translational Psychiatry Antidepressants affect gut microbiota and Ruminococcus flavefaciens is able to abolish their effects on depressive-like behavior | Translational Psychiatry](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41398-019-0466-x/MediaObjects/41398_2019_466_Fig1_HTML.png)